123ArticleOnline.com: james hebrewhttps://www.123articleonline.com/rss/author/319915/james-hebrewArticles written by james hebrew from 123ArticleOnline.comen-usCopyright (c) 123ArticleOnline.com All rights reserved. Drug Repurposing Service Providers Market, 2020-2030 By Roots Analysis https://www.123articleonline.com/articles/1262238/drug-repurposing-service-providers-market-2020-2030-by-roots-analysis Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs Elastomeric Closure Components Market For Vials, Cartridges and Syringes by Roots Analysis https://www.123articleonline.com/articles/1261521/elastomeric-closure-components-market-for-vials-cartridges-and-syringes-by-roots-analysis Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile materials; in this context, elastomers have demonstrated significant potential Human Microbiome Market, 2019-2030 by Roots Analysis https://www.123articleonline.com/articles/1262843/human-microbiome-market-2019-2030-by-roots-analysis Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, Roots Analysis https://www.123articleonline.com/articles/1256603/human-microbiome-based-products-market-is-projected-to-be-worth-usd-4-billion-by-2030-roots-analysis Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market By Rootsanalysis https://www.123articleonline.com/articles/1262257/liquid-biopsy-and-other-non-invasive-cancer-diagnostics-market-by-rootsanalysis Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access Manufacturing Market Continuous by Roots Analysis https://www.123articleonline.com/articles/1261487/manufacturing-market-continuous-by-roots-analysis Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing Patient Recruitment and Retention Services Marker, 2019-2030 by Roots Analysis https://www.123articleonline.com/articles/1262806/patient-recruitment-and-retention-services-marker-2019-2030-by-roots-analysis A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by 2030, growing at a CAGR of 10.7%,by Roots Analysis https://www.123articleonline.com/articles/1258956/the-biopharmaceutical-contract-biomanufacturing-market-is-projected-to-be-worth-usd-324-billion-by-2030-growing-at-a-cagr-of-107by-roots-analysis Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030 https://www.123articleonline.com/articles/1258883/the-car-t-therapies-market-is-characterized-by-a-healthy-pipeline-of-promising-therapies-and-is-projected-to-be-worth-around-usd-14-billion-in-2030 Given the success of approved CAR-T cell therapies, such as KYMRIAHÂ, YESCARTAÂ, TECARTUS and BREYANZIÂ, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis https://www.123articleonline.com/articles/1257873/the-drug-repurposing-service-providers-market-is-estimated-to-be-worth-usd-12-billion-in-2030-predicts-roots-analysis Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30% https://www.123articleonline.com/articles/1259690/the-endocannabinoid-system-targeted-therapeutics-market-is-projected-to-be-over-usd-5-billion-by-2030-growing-at-an-annualized-rate-of-30 So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions The gene therapy market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis https://www.123articleonline.com/articles/1256604/the-gene-therapy-market-is-projected-to-be-worth-usd-146-billion-in-2030-growing-at-a-cagr-of-30-over-the-next-decade-claims-roots-analysis Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth, till 2030 The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis https://www.123articleonline.com/articles/1259625/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-107-claims-roots-analysis Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis https://www.123articleonline.com/articles/1260736/the-microbial-contract-biomanufacturing-market-is-projected-to-be-worth-usd-93-billion-by-2030-growing-at-a-cagr-of-87-claims-roots-analysis The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030, predicts Roots Analysis https://www.123articleonline.com/articles/1257874/the-non-invasive-cancer-diagnostics-market-is-estimated-to-be-worth-around-usd-201-billion-by-2030-predicts-roots-analysis Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access